|
Volume 272, Number 34,
Issue of August 22, 1997
pp. 21334-21340
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Critical Cytoplasmic Domains of Human Interleukin-9 Receptor Chain in Interleukin-9-mediated Cell Proliferation and Signal
Transduction
(Received for publication, December 9, 1996, and in revised form, June 13, 1997)
Yuan Xiao
Zhu
§
,
Hui Bin
Sun
§
,
Monica Lik-Shing
Tsang
¶
,
Jon
McMahel
,
Susan
Grigsby
,
Tinggui
Yin
§
and
Yu-Chung
Yang
§
From the Departments of Medicine
(Hematology/Oncology) and Biochemistry and Molecular Biology,
Indiana University School of Medicine and the § Walther
Cancer Institute, Indianapolis, Indiana 46202 and ¶ R & D Systems,
Minneapolis, Minnesota 55413-2647
Interleukin-9 receptor (IL-9R) complex consists
of a ligand-specific chain and IL-2R chain. In this study, two
regions in the cytoplasmic domain of human IL-9R were found to be
important for IL-9-mediated cell growth. A membrane-proximal region
that contains the BOX1 consensus sequence is required for IL-9-induced cell proliferation and tyrosine phosphorylation of Janus kinases (JAKs). Deletion of this region or internal deletion of the BOX1 motif
abrogated IL-9-induced cell proliferation and signal transduction. However, substitution of the Pro-X-Pro in the BOX1 motif
with Ala-X-Ala failed to abolish IL-9-induced cell
proliferation but decreased IL-9-mediated tyrosine phosphorylation of
JAK kinases, insulin receptor substrate-2, and signal transducer and
activator of transcription 3 (STAT3) and expression of c-myc
and junB. Another important region is downstream of
the BOX1 motif and contains a STAT3 binding motif YLPQ. Deletion of
this region significantly impaired IL-9-induced cell growth, activation
of JAK kinases, insulin receptor substrate-2, and STAT3 and expression
of early response genes. A point mutation changing YLPQ into YLPA
greatly reduced IL-9-induced activation of STAT3 and expression of
c-myc but did not affect cell proliferation. These results
suggest that cooperation or cross-talk of signaling molecules
associated with different domains of IL-9R other than STAT3 is
essential for IL-9-mediated cell growth.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. S. Gounni, Q. Hamid, S. M. Rahman, J. Hoeck, J. Yang, and L. Shan
IL-9-Mediated Induction of Eotaxin1/CCL11 in Human Airway Smooth Muscle Cells
J. Immunol.,
August 15, 2004;
173(4):
2771 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xiao, J. Chung, H.-Y. Kao, and Y.-C. Yang
Tip60 Is a Co-repressor for STAT3
J. Biol. Chem.,
March 21, 2003;
278(13):
11197 - 11204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kloek, A. K. Haq, S. L. Dunn, H. J. Lavery, A. S. Banks, and M. G. Myers Jr.
Regulation of Jak Kinases by Intracellular Leptin Receptor Sequences
J. Biol. Chem.,
October 25, 2002;
277(44):
41547 - 41555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Brown and N. R. Kamal
The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications
Ann. Clin. Lab. Sci.,
October 1, 2002;
32(4):
339 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xiao, T. Yin, X.-Y. Wang, T. Uchida, J. Chung, M. F. White, and Y.-C. Yang
Specificity of Interleukin-2 Receptor gamma Chain Superfamily Cytokines Is Mediated by Insulin Receptor Substrate-dependent Pathway
J. Biol. Chem.,
March 1, 2002;
277(10):
8091 - 8098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Sheridan, T. Force, H.-J. Yoon, E. O'Leary, G. Choukroun, M. R. Taheri, and J. V. Bonventre
PLIP, a Novel Splice Variant of Tip60, Interacts with Group IV Cytosolic Phospholipase A2, Induces Apoptosis, and Potentiates Prostaglandin Production
Mol. Cell. Biol.,
July 15, 2001;
21(14):
4470 - 4481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P Sayeski and K. E Bernstein
Review: Signal transduction mechanisms of the angiotensin II type AT1-receptor: looking beyond the heterotrimeric G protein paradigm
Journal of Renin-Angiotensin-Aldosterone System,
March 1, 2001;
2(1):
4 - 10.
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Yen, Y.-C. Yang, S. K. Ruscetti, R. A. Kirken, R. M. Dai, and C.-C. H. Li
Involvement of the Ubiquitin-Proteasome Pathway in the Degradation of Nontyrosine Kinase-Type Cytokine Receptors of IL-9, IL-2, and Erythropoietin
J. Immunol.,
December 1, 2000;
165(11):
6372 - 6380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-B. Demoulin, C. Uyttenhove, D. Lejeune, A. Mui, B. Groner, and J.-C. Renauld
STAT5 Activation Is Required for Interleukin-9-dependent Growth and Transformation of Lymphoid Cells
Cancer Res.,
July 1, 2000;
60(14):
3971 - 3977.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. L. Orchansky, R. Kwan, F. Lee, and J. W. Schrader
Characterization of the Cytoplasmic Domain of Interleukin-13 Receptor-alpha
J. Biol. Chem.,
July 23, 1999;
274(30):
20818 - 20825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B. Sun, Y. X. Zhu, T. Yin, G. Sledge, and Y.-C. Yang
MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity
PNAS,
November 10, 1998;
95(23):
13555 - 13560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Grasso, M. Huang, C. D. Sullivan, C. J. Messler, M. B. Kiser, C. R. Dragwa, K. J. Holroyd, J.-C. Renauld, R. C. Levitt, and N. C. Nicolaides
Molecular Analysis of Human Interleukin-9 Receptor Transcripts in Peripheral Blood Mononuclear Cells. IDENTIFICATION OF A SPLICE VARIANT ENCODING FOR A NONFUNCTIONAL CELL SURFACE RECEPTOR
J. Biol. Chem.,
September 11, 1998;
273(37):
24016 - 24024.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|